TerminatedNCT01842542
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
Device studyAges 18–50United StatesDepression
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 50 years. Other eligibility criteria apply.
- Listed locations
- Hartford and 7 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 2013
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 25
- Sponsor
- Neuronetics
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01842542
- Official title
Show the full official title
An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hartford · Gainesville · Pensacola
5 more locations
- Chicago
- Louisville
- New York
- Allentown
- Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Neuronetics.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 50 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
